Инструкция по применению TUXIFLUD
Содержание инструкции
- Tuxiflud 3 mg/ml Syrup - 150 ml Bottle, 0.75% Solution for Nebulization
- Tuxiflud 15 mg/ 2 ml Solution for Nebulization
Tuxiflud 3 mg/ml Syrup - 150 ml Bottle, 0.75% Solution for Nebulization
40 ml Bottle
Tuxiflud 15 mg/ 2 ml Solution for Nebulization
15 single-dose containers
Tuxiflud 15 mg/ 2 ml solution for nebulization - 6 Vials 2 ml
Generic medicine
COMPOSITION
Tuxiflud 3 mg/ml Syrup - 150 ml Bottle.
100 ml of syrup contains: Active ingredient:Ambroxol hydrochloride 300 mg.
Excipients:Sucrose; Methyl p-hydroxybenzoate; Propyl p-hydroxybenzoate; Cherry aroma;
Purified water.
Tuxiflud 0.75 % Solution for Nebulization - 40 ml Bottle
100 ml of solution contains: Active ingredient:Ambroxol hydrochloride 750 mg.
Excipients:Citric acid monohydrate; Disodium phosphate dodecahydrate; Sodium chloride;
Benzalkonium chloride; Purified water.
Tuxiflud 15 mg/2 ml Solution for Nebulization
15 single-dose 2 ml containers
100 ml of 0.75% solution contains: Active ingredient:Ambroxol hydrochloride 750 mg.
Excipients:Sodium chloride, Methyl p-hydroxybenzoate, Propyl p-hydroxybenzoate, Purified water.
A single-dose container contains 15 mg of ambroxol hydrochloride.
Tuxiflud 15 mg/2 ml
Solution for Nebulization - 6 vials 2 ml
One vial contains: Active ingredient:Ambroxol hydrochloride 15 mg.
Excipients:Citric acid; Disodium phosphate; Sodium chloride; Water for injections.
PHARMACEUTICAL FORM AND CONTENT
Tuxiflud 3 mg/ml syrup :
Pack containing a 150 ml bottle at 0.3%, oral use
Tuxiflud 0.75 % Solution for Nebulization:
Pack with 1 Bottle of 40 ml
Tuxiflud 15 mg/2 ml Solution for Nebulization
Pack of 15 single-dose 2 ml containers of 0.75% solution for aerosol therapy
Tuxiflud 15 mg/2 ml Solution for Nebulization
Pack of 6 vials of 2 ml
PHARMACOTHERAPEUTIC CATEGORY
Mucolytic.
A.I.C. HOLDER
DYMALIFE PHARMACEUTICAL S.r.l.
Via Bagnulo, 95 – 80063 - Piano di Sorrento – Italy
MANUFACTURERS AND FINAL CONTROLLERS
Tuxiflud 3 mg/ml syrup
Officina Farmaceutica FRANCIA FARMACEUTICI Industria Farmaco Biologica S.r.l.
Via dei Pestagalli.7 - Milan
Laboratorio Italiano Biochimico Farmaceutico Lisapharma S.p.A.
Via Licino, 11 - 22036 Erba - (CO).
Tuxiflud 0.75 % Solution for Nebulization - 40 ml Bottle
Special Product's Line S.p.A. Via Campobello, 15 - Pomezia (Rome)
Tuxiflud 15 mg/2 ml Solution for Nebulization - 15 mg vials
- 1) IBSA Farmaceutici Italia S.r.l. -Via Martiri di Cefalonia, 2 - 26900 LODI
- 2) Special Product's Line S.p.A. Via Campobello, 15 - Pomezia (Rome)
Tuxiflud 15 mg/2 ml Solution for Nebulization - single-dose containers
Officina Farmaceutica COC Farmaceutici S.r.l. - S. Agata Bolognese (BO)
THERAPEUTIC INDICATIONS
Treatment of secretion disorders in acute and chronic bronchopulmonary conditions.
CONTRAINDICATIONS
Hypersensitivity to the active ingredient or to any of the excipients.
Severe hepatic and/or renal impairment.
Tuxiflud “3 mg/ml Syrup” is contraindicated in children under 2 years of age.
PRECAUTIONS FOR USE
Mucolytics can cause bronchial obstruction in children under 2 years of age. In fact, the
ability to drain bronchial mucus is limited in this age group, due to the
physiological characteristics of the respiratory tract. They should therefore not be used in children
under 2 years of age (for the syrup).
Tuxiflud should be administered with caution in patients with peptic ulcer.
Tuxiflud 0.75 % solution for nebulizer in 40 ml bottle contains benzalkonium chloride as
preservative. Especially when using the medicine for long periods, benzalkonium chloride can
cause swelling of the nasal mucosa. If such a reaction is suspected (persistent nasal congestion), a
medicine for nasal use without BAC should be used if possible. If such
medicines for nasal use without BAC are not available, another
pharmaceutical form should be considered. In addition, benzalkonium chloride can cause bronchospasm.
INTERACTIONS
Tuxiflud generally does not interfere with other drugs.
SPECIAL WARNINGS
Cases of severe skin reactions associated with the administration of Ambroxol have been reported.
If you develop a skin rash (including lesions of mucous membranes such as mouth, throat, nose,
eyes, genitals), stop taking Ambroxol and seek immediate medical attention.
Tuxiflud in 15 mg/2ml solution for nebulization in 15 single-dose containers and 3
mg/ml syrup contain: methyl parahydroxybenzoateand propyl parahydroxybenzoate: mild
irritants for skin, eyes and mucous membranes. They can increase the risk of jaundice in newborns.
Pregnancy and breastfeeding
During pregnancy and breastfeeding, ambroxol should only be used after consulting a doctor and
weighing the risk/benefit ratio in your own case with him.
Consult your doctor if you suspect you are pregnant or plan to
become pregnant.
No clinical data are available regarding pregnancies exposed to ambroxol.
Animal studies do not indicate direct or indirect harmful effects on pregnancy, embryonic/fetal development, labor or postnatal development. Caution is necessary when prescribing the medicine to
pregnant women. Drugs should only be used during pregnancy if the expected benefit
for the mother is considered greater than the risk to the fetus. All drugs should be
avoided, if possible, during the first trimester of pregnancy. The drug is secreted into breast milk.
The use of ambroxol by the mother can cause undesirable effects in the infant; therefore
it is necessary to decide whether to discontinue breastfeeding or treatment with the medicine, taking
into account the importance of the drug for the mother.
DOSAGE, ADMINISTRATION AND DURATION OF TREATMENT
Solution for Nebulization
Adults and children over 5 years of age:2-3 ml of solution 1-2 times a day.
Children under 5 years of age:2 ml of solution 1-2 times a day.
Since coughing may occur during deep breathing of aerosol, try to
breathe normally during inhalation. It is recommended to warm the solution to body
temperature before inhalation.
In patients with asthma, it is recommended to administer the usual
bronchodilator before inhalation.
The solution for nebulization can be administered using standard aerosol therapy devices. It can also be diluted with distilled water in a 1:1 ratio.
Instructions for use of the single-dose container
To use the single-dose container, perform the following operations:
- 1) Isolate a container from the strip.
- 2) Open the single-dose container by rotating the tab.
- 3) By exerting moderate pressure on the walls of the single-dose container, release the medicine into the prescribed quantity.
- 4) If using half the dose, the container can be closed by turning it over and pressing the cap. The remaining quantity should be used within 24 hours. Solution for NebulizationAdults and children over 5 years of age:2-3 ml of solution 1-2 times a day. Children under 5 years of age:2 ml of solution 1-2 times a day. Since coughing may occur during deep breathing of aerosol, try to breathe normally during inhalation. It is recommended to warm the solution to body temperature before inhalation. In patients with asthma, it is recommended to administer the usual bronchodilator before inhalation. The solution for nebulization can be administered using standard aerosol therapy devices. It can also be diluted with distilled water in a 1:1 ratio.
Syrup
Adults:10 ml (30 mg) 3 times a day.
Children from 2 to 5 years:2.5 ml (7.5 mg) 3 times a day.
Children over 5 years:5 ml (15 mg) 3 times a day.
It is recommended to take the syrup after meals.
Vials for inhalation use
Adults: 2-3 vials per day. Children up to 5 years: 1-2 vials per day. Children over 5 years: 2-3 vials per day.
Instructions for use :Breakable vials, no file needed.
Do not use ambroxol for prolonged treatments.
OVERDOSAGE
Data on ambroxol overdose are limited.
Symptoms corresponding to the described adverse effects are expected.
In case of accidental ingestion/intake of an excessive dose of ambroxol, immediately
inform your doctor or go to the nearest hospital.
UNDESIRABLE EFFECTS
Rarely: fatigue, dry mouth, rhinorrhea, dysuria, headache, gastrointestinal
disorders (pyrosis, dyspepsia, constipation, nausea and vomiting), contact dermatitis or other allergic
reactions (especially skin rashes).
Rare: may affect up to 1 in 1000 people:
Hypersensitivity reactions
Rash, urticaria
Not known: frequency cannot be defined on the basis of available data
Severe skin reactions (including erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis and acute generalized pustulosis).
Reporting of adverse reactions
If you experience any side effects, including those not listed in this leaflet, tell your
doctor, pharmacist or nurse. You can also report side effects directly through http://www.agenziafarmaco.gov.it/it/responsabili.
By reporting side effects you can help provide more information on the safety
of this medicine.
EXPIRY DATE AND STORAGE
Check the expiry date indicated on the packaging.
The expiry date refers to the product in intact packaging, stored correctly.
Caution: do not use the medicine after that date.
KEEP THE MEDICINE OUT OF THE REACH AND SIGHT OF CHILDREN.
- Страна регистрации
- Форма выпускаSyrup, 3 MG/ML
- Код АТХR05CB06
- Действующее вещество
- Отпускается по рецептуНет
- Производитель
- Информация на этой странице носит справочный характер и не является медицинской консультацией. Перед началом приема лекарства обязательно проконсультируйтесь с врачом.
- Аналоги TUXIFLUDФорма выпуска: Solution for nebulization, 15 MG/2 MLДействующее вещество: АмброксолПроизводитель: EPIFARMA S.R.LОтпускается без рецептаФорма выпуска: Solution for nebulization, 15 MG/2 MLДействующее вещество: АмброксолПроизводитель: TECNIGEN S.R.L.Отпускается без рецептаФорма выпуска: Coated tablet, 30 MGДействующее вещество: АмброксолПроизводитель: ABC FARMACEUTICI S.P.A.Отпускается по рецепту
Аналоги TUXIFLUD в других странах
Лекарства с тем же действующим веществом, доступные в других странах.
Аналог TUXIFLUD в Испания
Аналог TUXIFLUD в Польша
Аналог TUXIFLUD в Украина
Врачи онлайн по TUXIFLUD
Обсудите применение TUXIFLUD и возможные следующие шаги — по оценке врача.
Получите рецепт на TUXIFLUD онлайн
Заполните форму за 2 минуты
Расскажите о симптомах, истории болезни и нужном препарате.
Выберите врача или мы назначим
Выберите специалиста или мы подберём ближайшего доступного врача.
Врач рассматривает ваш случай
Обычно в течение 30 минут. Может задать уточняющие вопросы в чате.
Получите в любой аптеке
Электронный рецепт отправляется на вашу почту — действителен по всей Польше.
Часто задаваемые вопросы
TUXIFLUD не требует рецепта в Италия. Вы можете уточнить у врача онлайн, подходит ли это лекарство для вашей ситуации.
Действующее вещество TUXIFLUD — Амброксол. Эта информация помогает определить лекарства с тем же составом под другими торговыми названиями.
TUXIFLUD производится компанией DYMALIFE PHARMACEUTICAL S.R.L.. Упаковка и торговое название могут отличаться в зависимости от дистрибьютора.
Врачи, включая Семейные врачи, Психиатры, Дерматологи, Кардиологи, Эндокринологи, Гастроэнтерологи, Пульмонологи, Нефрологи, Ревматологи, Гематологи, Инфекционисты, Аллергологи, Гериатры, Педиатры, Онкологи, могут оценить целесообразность применения TUXIFLUD с учетом вашей ситуации и местных правил. Вы можете записаться на онлайн-консультацию, чтобы обсудить возможные варианты.
Польша имеет хорошо развитую систему здравоохранения в крупных городах, таких как Варшава, Краков, Вроцлав и Гданьск. Аптеки широко доступны и работают в соответствии с действующим законодательством, обеспечивая доступ к рецептурным препаратам.
Вы можете купить TUXIFLUD в Варшаве, Кракове, Вроцлаве или Гданьске в любой аптеке при наличии действующего рецепта.
Чтобы получить рецепт, вы можете воспользоваться Oladoctor:
Другие лекарства с тем же действующим веществом (Амброксол) включают AMBROTUS, AMBROXOL TEKNIJEN, AMBROXOLO ABK. Они могут отличаться торговым названием или формой выпуска, но содержат одинаковый терапевтический компонент. Перед изменением лечения рекомендуется проконсультироваться с врачом.
















